Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.

Autor: Martínez-Lago N; Medical Oncology Department, University Hospital A Coruña, A Coruña, Spain., Cameselle García S; Medical Oncology Department, Ourense University Hospital Complex, Ourense, Spain., Alonso de Castro B; Medical Oncology Department, University Hospital A Coruña, A Coruña, Spain., Gómez-Randulfe Rodríguez MI; Medical Oncology Department, University Hospital A Coruña, A Coruña, Spain., Carmona Campos M; Medical Oncology Department, University Hospital Lucus Augusti, Lugo, Spain., González Villarroel P; Medical Oncology Department, Alvaro Cunqueiro University Hospital, Vigo, Spain., Salgado Fernández M; Medical Oncology Department, Ourense University Hospital Complex, Ourense, Spain., De la Cámara Gómez JC; Medical Oncology Department, University Hospital A Coruña, A Coruña, Spain., Romero Reinoso C; Medical Oncology Department, POVISA, Vigo, Spain., Cousillas Castiñeiras A; Medical Oncology Department, Pontevedra University Hospital Complex, Pontevedra, Vigo, Spain., Méndez Méndez JC; Medical Oncology Department, Centro Oncológico de Galicia, A Coruña, Spain., Vidal Insua Y; Medical Oncology Department, Santiago University Hospital Complex, Santiago de Compostela, A Coruña, Spain., Fernández-Montes A; Medical Oncology Department, Ourense University Hospital Complex, Ourense, Spain.

Publikováno v: PloS one [PLoS One] 2022 Jun 03; Vol. 17 (6), pp. e0269399. Date of Electronic Publication: 2022 Jun 03 (Print Publication: 2022).